Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 25 entries
Sorted by: Best Match Show Resources per page
Defining 17OHP-C responsiveness.

American journal of obstetrics and gynecology

Nelson DB, McIntire DD, Leveno KJ.
PMID: 30790571
Am J Obstet Gynecol. 2019 Jun;220(6):608. doi: 10.1016/j.ajog.2019.02.032. Epub 2019 Feb 18.

No abstract available.

Cite
Nelson DB, McIntire DD, Leveno KJ. Defining 17OHP-C responsiveness. Am J Obstet Gynecol. 2019;220(6):608doi: 10.1016/j.ajog.2019.02.032.
Nelson, D. B., McIntire, D. D., & Leveno, K. J. (2019). Defining 17OHP-C responsiveness. American journal of obstetrics and gynecology, 220(6), 608. https://doi.org/10.1016/j.ajog.2019.02.032
Nelson, David B, et al. "Defining 17OHP-C responsiveness." American journal of obstetrics and gynecology vol. 220,6 (2019): 608. doi: https://doi.org/10.1016/j.ajog.2019.02.032
Nelson DB, McIntire DD, Leveno KJ. Defining 17OHP-C responsiveness. Am J Obstet Gynecol. 2019 Jun;220(6):608. doi: 10.1016/j.ajog.2019.02.032. Epub 2019 Feb 18. PMID: 30790571.
Copy Download .nbib Format: NLM
A Systematic Approach to Translating Evidence into Practice to Reduce Infant Mortality.

Maternal and child health journal

Leslie ETA, Buntin MB.
PMID: 30030743
Matern Child Health J. 2018 Nov;22(11):1550-1555. doi: 10.1007/s10995-018-2608-9.

Purpose To provide recommendations for improving rates of infant mortality in a U.S. southeastern city using a collective impact approach. Description A convening organization and its academic partner devised a systematic process involving national experts and local stakeholders. Assessment...

Cite
Leslie ETA, Buntin MB. A Systematic Approach to Translating Evidence into Practice to Reduce Infant Mortality. Matern Child Health J. 2018;22(11):1550-1555doi: 10.1007/s10995-018-2608-9.
Leslie, E. T. A., & Buntin, M. B. (2018). A Systematic Approach to Translating Evidence into Practice to Reduce Infant Mortality. Maternal and child health journal, 22(11), 1550-1555. https://doi.org/10.1007/s10995-018-2608-9
Leslie, Erika T A, and Buntin, Melinda B. "A Systematic Approach to Translating Evidence into Practice to Reduce Infant Mortality." Maternal and child health journal vol. 22,11 (2018): 1550-1555. doi: https://doi.org/10.1007/s10995-018-2608-9
Leslie ETA, Buntin MB. A Systematic Approach to Translating Evidence into Practice to Reduce Infant Mortality. Matern Child Health J. 2018 Nov;22(11):1550-1555. doi: 10.1007/s10995-018-2608-9. PMID: 30030743.
Copy Download .nbib Format: NLM
Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety.

Therapeutics and clinical risk management

How HY, Sibai BM.
PMID: 19436604
Ther Clin Risk Manag. 2009 Feb;5(1):55-64. Epub 2009 Mar 26.

Preterm birth is the leading cause of neonatal mortality and morbidity and long-term disability of non-anomalous infants. Previous studies have identified a prior early spontaneous preterm birth as the risk factor with the highest predictive value for recurrence. Two...

Cite
How HY, Sibai BM. Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety. Ther Clin Risk Manag. 2009;5(1):55-64
How, H. Y., & Sibai, B. M. (2009). Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety. Therapeutics and clinical risk management, 5(1), 55-64.
How, Helen Y, and Sibai, Baha M. "Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety." Therapeutics and clinical risk management vol. 5,1 (2009): 55-64.
How HY, Sibai BM. Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety. Ther Clin Risk Manag. 2009 Feb;5(1):55-64. Epub 2009 Mar 26. PMID: 19436604; PMCID: PMC2697509.
Copy Download .nbib Format: NLM
17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials.

Frontiers in medicine

Almutairi AR, Aljohani HI, Al-Fadel NS.
PMID: 34926508
Front Med (Lausanne). 2021 Dec 01;8:764855. doi: 10.3389/fmed.2021.764855. eCollection 2021.

No abstract available.

Cite
Almutairi AR, Aljohani HI, Al-Fadel NS. 17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials. Front Med (Lausanne). 2021;8:764855doi: 10.3389/fmed.2021.764855.
Almutairi, A. R., Aljohani, H. I., & Al-Fadel, N. S. (2021). 17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials. Frontiers in medicine, 8764855. https://doi.org/10.3389/fmed.2021.764855
Almutairi, Abdulaali R, et al. "17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials." Frontiers in medicine vol. 8 (2021): 764855. doi: https://doi.org/10.3389/fmed.2021.764855
Almutairi AR, Aljohani HI, Al-Fadel NS. 17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials. Front Med (Lausanne). 2021 Dec 01;8:764855. doi: 10.3389/fmed.2021.764855. eCollection 2021. PMID: 34926508; PMCID: PMC8671739.
Copy Download .nbib Format: NLM
Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth.

Facts, views & vision in ObGyn

Kuon RJ, Garfield RE.
PMID: 24753898
Facts Views Vis Obgyn. 2012;4(2):110-9.

The importance of progesterone (P4) for maintenance of pregnancy, its role in cervical ripening and uterine contractions is at least partly established and therefore, not surprisingly, the basis for the concept to use P4 as a treatment for preterm...

Cite
Kuon RJ, Garfield RE. Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth. Facts Views Vis Obgyn. 2012;4(2):110-9
Kuon, R. J., & Garfield, R. E. (2012). Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth. Facts, views & vision in ObGyn, 4(2), 110-9.
Kuon, R-J, and Garfield, R E. "Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth." Facts, views & vision in ObGyn vol. 4,2 (2012): 110-9.
Kuon RJ, Garfield RE. Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth. Facts Views Vis Obgyn. 2012;4(2):110-9. PMID: 24753898; PMCID: PMC3987504.
Copy Download .nbib Format: NLM
Nonclassic congenital adrenal hyperplasia misdiagnosed as Turner syndrome.

Journal of human reproductive sciences

Mishra VV, Pritti K, Aggarwal R, Choudhary S.
PMID: 26751945
J Hum Reprod Sci. 2015 Oct-Dec;8(4):239-41. doi: 10.4103/0974-1208.170416.

We present a patient with nonclassic congenital adrenal hyperplasia (NCAH) misdiagnosed as mosaic Turner syndrome. She presented with complaints of primary infertility. Short stature, the presence of facial hair and hoarse voice was also noted. She had primary amenorrhea...

Cite
Mishra VV, Pritti K, Aggarwal R, et al. Nonclassic congenital adrenal hyperplasia misdiagnosed as Turner syndrome. J Hum Reprod Sci. 2015;8(4):239-41doi: 10.4103/0974-1208.170416.
Mishra, V. V., Pritti, K., Aggarwal, R., & Choudhary, S. (2015). Nonclassic congenital adrenal hyperplasia misdiagnosed as Turner syndrome. Journal of human reproductive sciences, 8(4), 239-41. https://doi.org/10.4103/0974-1208.170416
Mishra, Vineet V, et al. "Nonclassic congenital adrenal hyperplasia misdiagnosed as Turner syndrome." Journal of human reproductive sciences vol. 8,4 (2015): 239-41. doi: https://doi.org/10.4103/0974-1208.170416
Mishra VV, Pritti K, Aggarwal R, Choudhary S. Nonclassic congenital adrenal hyperplasia misdiagnosed as Turner syndrome. J Hum Reprod Sci. 2015 Oct-Dec;8(4):239-41. doi: 10.4103/0974-1208.170416. PMID: 26751945; PMCID: PMC4691978.
Copy Download .nbib Format: NLM
Comparison the efficacy of vaginal progesterone .

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Alavi A, Ranjbar A, Atighpoor F, Zare S.
PMID: 34470137
J Matern Fetal Neonatal Med. 2021 Sep 01;1-7. doi: 10.1080/14767058.2021.1949451. Epub 2021 Sep 01.

OBJECTIVE: The aim of this study was to compare the effect of vaginal progesterone with 17-alpha-hydroxyprogesterone caproate (17OHP-C) in prevention of preterm birth in high-risk pregnant women undergo cerclage.MATERIALS AND METHODS: This prospective randomized clinical trial registered in the...

Cite
Alavi A, Ranjbar A, Atighpoor F, et al. Comparison the efficacy of vaginal progesterone . J Matern Fetal Neonatal Med. 2021;1-7doi: 10.1080/14767058.2021.1949451.
Alavi, A., Ranjbar, A., Atighpoor, F., & Zare, S. (2021). Comparison the efficacy of vaginal progesterone . The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-7. https://doi.org/10.1080/14767058.2021.1949451
Alavi, Azin, et al. "Comparison the efficacy of vaginal progesterone ." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2021): 1-7. doi: https://doi.org/10.1080/14767058.2021.1949451
Alavi A, Ranjbar A, Atighpoor F, Zare S. Comparison the efficacy of vaginal progesterone . J Matern Fetal Neonatal Med. 2021 Sep 01;1-7. doi: 10.1080/14767058.2021.1949451. Epub 2021 Sep 01. PMID: 34470137.
Copy Download .nbib Format: NLM
Adrenocortical Carcinoma in a 6-Month-Old Infant.

Journal of Indian Association of Pediatric Surgeons

Rahar S, Chauhan DS, Singh S, Ahuja A, Bhardwaj M, Sen A.
PMID: 33343113
J Indian Assoc Pediatr Surg. 2020 Sep-Oct;25(5):310-313. doi: 10.4103/jiaps.JIAPS_155_19. Epub 2020 Sep 01.

Adrenocortical carcinoma (ACC) is a rare malignant tumor arising from the adrenal cortex and it is even rarer in infancy. These tumors are usually hormonally active. We report a case of ACC in a 6-month-old infant who was brought...

Cite
Rahar S, Chauhan DS, Singh S, et al. Adrenocortical Carcinoma in a 6-Month-Old Infant. J Indian Assoc Pediatr Surg. 2020;25(5):310-313doi: 10.4103/jiaps.JIAPS_155_19.
Rahar, S., Chauhan, D. S., Singh, S., Ahuja, A., Bhardwaj, M., & Sen, A. (2020). Adrenocortical Carcinoma in a 6-Month-Old Infant. Journal of Indian Association of Pediatric Surgeons, 25(5), 310-313. https://doi.org/10.4103/jiaps.JIAPS_155_19
Rahar, Seema, et al. "Adrenocortical Carcinoma in a 6-Month-Old Infant." Journal of Indian Association of Pediatric Surgeons vol. 25,5 (2020): 310-313. doi: https://doi.org/10.4103/jiaps.JIAPS_155_19
Rahar S, Chauhan DS, Singh S, Ahuja A, Bhardwaj M, Sen A. Adrenocortical Carcinoma in a 6-Month-Old Infant. J Indian Assoc Pediatr Surg. 2020 Sep-Oct;25(5):310-313. doi: 10.4103/jiaps.JIAPS_155_19. Epub 2020 Sep 01. PMID: 33343113; PMCID: PMC7732005.
Copy Download .nbib Format: NLM
17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials.

Obstetrics & gynecology science

Baradwan S, Abdulghani SH, Abuzaid M, Khadawardi K, Alshahrani MS, Al-Matary A, AlRasheed MA, Miski NT, Abdulhalim A, Alturki YM, Abu-Zaid A.
PMID: 34670064
Obstet Gynecol Sci. 2021 Nov;64(6):484-495. doi: 10.5468/ogs.21264. Epub 2021 Oct 20.

To perform a systematic review and meta-analysis of all randomized controlled trials (RCTs) that investigated the clinical benefits of 17-alpha hydroxyprogesterone caproate (17OHPC) in the prevention of recurrent preterm birth (PTB) among singleton pregnant women with a previous history...

Cite
Baradwan S, Abdulghani SH, Abuzaid M, et al. 17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials. Obstet Gynecol Sci. 2021;64(6):484-495doi: 10.5468/ogs.21264.
Baradwan, S., Abdulghani, S. H., Abuzaid, M., Khadawardi, K., Alshahrani, M. S., Al-Matary, A., AlRasheed, M. A., Miski, N. T., Abdulhalim, A., Alturki, Y. M., & Abu-Zaid, A. (2021). 17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials. Obstetrics & gynecology science, 64(6), 484-495. https://doi.org/10.5468/ogs.21264
Baradwan, Saeed, et al. "17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials." Obstetrics & gynecology science vol. 64,6 (2021): 484-495. doi: https://doi.org/10.5468/ogs.21264
Baradwan S, Abdulghani SH, Abuzaid M, Khadawardi K, Alshahrani MS, Al-Matary A, AlRasheed MA, Miski NT, Abdulhalim A, Alturki YM, Abu-Zaid A. 17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials. Obstet Gynecol Sci. 2021 Nov;64(6):484-495. doi: 10.5468/ogs.21264. Epub 2021 Oct 20. PMID: 34670064; PMCID: PMC8595047.
Copy Download .nbib Format: NLM
Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth.

Patient preference and adherence

Vidaeff AC, Belfort MA.
PMID: 23874089
Patient Prefer Adherence. 2013 Jul 11;7:683-91. doi: 10.2147/PPA.S35612. Print 2013.

Prevention of preterm delivery is a major desiderate in contemporary obstetrics and a societal necessity. The means to achieve this goal remain elusive. Progesterone has been used in an attempt to prevent preterm delivery since the 1970s, but the...

Cite
Vidaeff AC, Belfort MA. Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth. Patient Prefer Adherence. 2013;7:683-91doi: 10.2147/PPA.S35612.
Vidaeff, A. C., & Belfort, M. A. (2013). Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth. Patient preference and adherence, 7683-91. https://doi.org/10.2147/PPA.S35612
Vidaeff, Alex C, and Belfort, Michael A. "Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth." Patient preference and adherence vol. 7 (2013): 683-91. doi: https://doi.org/10.2147/PPA.S35612
Vidaeff AC, Belfort MA. Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth. Patient Prefer Adherence. 2013 Jul 11;7:683-91. doi: 10.2147/PPA.S35612. Print 2013. PMID: 23874089; PMCID: PMC3714001.
Copy Download .nbib Format: NLM
Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth.

Advanced biomedical research

Rouholamin S, Zarean E, Sadeghi L.
PMID: 26682208
Adv Biomed Res. 2015 Oct 29;4:242. doi: 10.4103/2277-9175.168609. eCollection 2015.

BACKGROUND: The mellitus exact role of 17-alpha hydroxyprogesterone caproate in increasing the rate of gestational diabetes mellitus (GDM) is still unclear. This study was aimed to investigate the association of treatment with 17-alpha hydroxyprogesterone caproate with GDM in pregnant...

Cite
Rouholamin S, Zarean E, Sadeghi L. Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth. Adv Biomed Res. 2015;4:242doi: 10.4103/2277-9175.168609.
Rouholamin, S., Zarean, E., & Sadeghi, L. (2015). Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth. Advanced biomedical research, 4242. https://doi.org/10.4103/2277-9175.168609
Rouholamin, Safoura, et al. "Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth." Advanced biomedical research vol. 4 (2015): 242. doi: https://doi.org/10.4103/2277-9175.168609
Rouholamin S, Zarean E, Sadeghi L. Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth. Adv Biomed Res. 2015 Oct 29;4:242. doi: 10.4103/2277-9175.168609. eCollection 2015. PMID: 26682208; PMCID: PMC4673703.
Copy Download .nbib Format: NLM
Comparison of Risk of Preterm Labor between Vaginal Progesterone and17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion: A Randomized Clinical Trial.

International journal of fertility & sterility

Beigi A, Esmailzadeh A, Pirjani R.
PMID: 27441048
Int J Fertil Steril. 2016 Jul-Sep;10(2):162-8. doi: 10.22074/ijfs.2016.4905. Epub 2016 Jun 01.

BACKGROUND: Threatened miscarriage is a common complication in pregnancy that leads to adverse pregnancy outcomes such as preterm labor. This study aimed to compare the vaginal progesterone (Cyclogest) versus 17-alpha-hydroxyprogesterone caproate (Proluton) on preventing preterm labor in pregnant women...

Cite
Beigi A, Esmailzadeh A, Pirjani R. Comparison of Risk of Preterm Labor between Vaginal Progesterone and17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion: A Randomized Clinical Trial. Int J Fertil Steril. 2016;10(2):162-8doi: 10.22074/ijfs.2016.4905.
Beigi, A., Esmailzadeh, A., & Pirjani, R. (2016). Comparison of Risk of Preterm Labor between Vaginal Progesterone and17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion: A Randomized Clinical Trial. International journal of fertility & sterility, 10(2), 162-8. https://doi.org/10.22074/ijfs.2016.4905
Beigi, Abootaleb, et al. "Comparison of Risk of Preterm Labor between Vaginal Progesterone and17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion: A Randomized Clinical Trial." International journal of fertility & sterility vol. 10,2 (2016): 162-8. doi: https://doi.org/10.22074/ijfs.2016.4905
Beigi A, Esmailzadeh A, Pirjani R. Comparison of Risk of Preterm Labor between Vaginal Progesterone and17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion: A Randomized Clinical Trial. Int J Fertil Steril. 2016 Jul-Sep;10(2):162-8. doi: 10.22074/ijfs.2016.4905. Epub 2016 Jun 01. PMID: 27441048; PMCID: PMC4948067.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 25 entries